Visara appoints ophthalmology leaders to advance VIS-101 drug program

Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program
(NASDAQ: AURA) Delayed: 7.02 +0.07 (1.01%)
Previous Close $6.95    52 Week High
Open $6.81    52 Week Low
Day High $7.28    P/E N/A 
Day Low $6.55    EPS
Volume 500,366       

(NASDAQ: FDMT) Delayed: 11.60 +1.18 (11.32%)
Previous Close $10.42    52 Week High
Open $10.22    52 Week Low
Day High $12.18    P/E N/A 
Day Low $10.22    EPS
Volume 2,068,949       

(NASDAQ: NBP) Delayed: 1.61 +0.08 (5.23%)
Previous Close $1.53    52 Week High $6.95 
Open $1.50    52 Week Low $6.95 
Day High $1.65    P/E 0.75 
Day Low $1.47    EPS $2.14 
Volume 424,159